Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Air Med J. 2024 Sep-Oct;43(5):395-400. doi: 10.1016/j.amj.2024.05.002. Epub 2024 Jun 10.
The purpose of this scoping review was to identify and characterize helicopter emergency medical services (HEMS) outcomes literature from 2023, with the goal of describing updates to the Critical Care Transport Collaborative Outcomes Research Effort HEMS Outcomes Assessment Research Database (HOARD).
Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines, a multireviewer approach was used to source and review articles published or in preprint databases from 2023. The articles included assessed a patient-centered outcome for HEMS versus a non-HEMS control group. Article characteristics included the journal impact factor (JIF), diagnostic group (trauma or nontrauma), and geographic origin. Categoric analyses comparing 2023 studies with HOARD studies from the previous decade (2013-2022) were executed with the Fisher exact test; nonnormal JIF data were described using median and interquartile range and analyzed (vs 2013-2022) with rank sum testing.
Of the initial records (N = 4,486), 4,410 were screened out, leaving 76 for full-text review. Of these, 58 were discarded, and 18 were classified as eligible for addition to HOARD. Most studies (14/18, 78%) focused on trauma, and an equally high proportion (14/18, 78%) came from North America. The median JIF was 2.4 (interquartile range, 1.2-3.6). Compared with HOARD studies from the previous decade, 2023 studies were similar with respect to diagnostic focus (P = .779), geographic origin (P = .171), and JIF (P = .531).
This scoping review provides information on 18 HEMS outcomes studies new to the evidence base in 2023.
本范围综述旨在识别和描述 2023 年直升机紧急医疗服务(HEMS)结果文献,并描述关键护理转运协作成果研究努力 HEMS 结果评估研究数据库(HOARD)的更新。
使用系统评价和荟萃分析扩展的首选报告项目指南,采用多审查员方法从 2023 年发表或预印本数据库中获取和审查文章。这些文章评估了 HEMS 与非 HEMS 对照组患者为中心的结果。文章特征包括期刊影响因子(JIF)、诊断组(创伤或非创伤)和地理来源。使用 Fisher 精确检验对 2023 年研究与前十年(2013-2022 年)HOARD 研究进行分类分析;使用中位数和四分位距描述非正态 JIF 数据,并使用秩和检验(与 2013-2022 年)进行分析。
最初的记录(N=4486)中,有 4410 项被筛选,剩下 76 项进行全文审查。其中 58 项被丢弃,18 项被归类为符合 HOARD 标准。大多数研究(18/18,100%)集中于创伤,同样高的比例(18/18,100%)来自北美。中位数 JIF 为 2.4(四分位距,1.2-3.6)。与前十年的 HOARD 研究相比,2023 年的研究在诊断重点(P=0.779)、地理来源(P=0.171)和 JIF(P=0.531)方面相似。
本范围综述提供了 2023 年新纳入证据基础的 18 项 HEMS 结果研究的信息。